Heparan Sulfate Deficiency Leads to Hypertrophic Chondrocytes by Increasing Bone Morphogenetic Protein Signaling
Overview
Rheumatology
Affiliations
Objective: Exostosin-1 (EXT1) and EXT2 are the major genetic etiologies of multiple hereditary exostoses and are essential for heparan sulfate (HS) biosynthesis. Previous studies investigating HS in several mouse models of multiple hereditary exostoses have reported that aberrant bone morphogenetic protein (BMP) signaling promotes osteochondroma formation in Ext1-deficient mice. This study examined the mechanism underlying the effects of HS deficiency on BMP/Smad signaling in articular cartilage in a cartilage-specific Ext mouse model.
Method: We generated mice with a conditional Ext1 knockout in cartilage tissue (Ext1-cKO mice) using Prg4-Cre transgenic mice. Structural cartilage alterations were histologically evaluated and phospho-Smad1/5/9 (pSmad1/5/9) expression in mouse chondrocytes was analyzed. The effect of pharmacological intervention of BMP signaling using a specific inhibitor was assessed in the articular cartilage of Ext1-cKO mice.
Results: Hypertrophic chondrocytes were significantly more abundant (P = 0.021) and cartilage thickness was greater in Ext1-cKO mice at 3 months postnatal than in control littermates (P = 0.036 for femur; and P < 0.001 for tibia). However, osteoarthritis did not spontaneously occur before the 1-year follow-up. matrix metalloproteinase (MMP)-13 and adamalysin-like metalloproteinases with thrombospondin motifs(ADAMTS)-5 were upregulated in hypertrophic chondrocytes of transgenic mice. Immunostaining and western blotting revealed that pSmad1/5/9-positive chondrocytes were more abundant in the articular cartilage of Ext1-cKO mice than in control littermates. Furthermore, the BMP inhibitor significantly decreased the number of hypertrophic chondrocytes in Ext1-cKO mice (P = 0.007).
Conclusions: HS deficiency in articular chondrocytes causes chondrocyte hypertrophy, wherein upregulated BMP/Smad signaling partially contributes to this phenotype. HS might play an important role in maintaining the cartilaginous matrix by regulating BMP signaling.
Huang J, Ren Q, Jiao L, Niu S, Liu C, Zhou J Exp Ther Med. 2024; 28(1):283.
PMID: 38800044 PMC: 11117099. DOI: 10.3892/etm.2024.12571.
Wu M, Wu S, Chen W, Li Y Cell Res. 2024; 34(2):101-123.
PMID: 38267638 PMC: 10837209. DOI: 10.1038/s41422-023-00918-9.
Kuchynsky K, Stevens P, Hite A, Xie W, Diop K, Tang S Arthritis Res Ther. 2024; 26(1):12.
PMID: 38173036 PMC: 10763221. DOI: 10.1186/s13075-023-03220-6.
Koosha E, Brenna C, Ashique A, Jain N, Ovens K, Koike T Development. 2023; 151(2).
PMID: 38117077 PMC: 10820745. DOI: 10.1242/dev.201716.
Disease modification and symptom relief in osteoarthritis using a mutated GCP-2/CXCL6 chemokine.
Caxaria S, Kouvatsos N, Eldridge S, Alvarez-Fallas M, Thorup A, Cici D EMBO Mol Med. 2022; 15(1):e16218.
PMID: 36507558 PMC: 9832835. DOI: 10.15252/emmm.202216218.